Ligand profile
CHEMBL4546270
Bioactivity hit from ChEMBL on a similar protein.
Bound to: Q8NG11
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL4546270- UniProt (similar protein)
P60033- pchembl
- 7.420 (~38.0 nM)
- Target protein
- Q8NG11
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 91.7
- −1 ≤ LogP ≤ 5 2.11
- MW ≤ 500 Da 268.3
- LogP ≤ 5 2.11
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 6
- TPSA ≤ 140 Ų 91.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC(=O)[C@@H]1C[C@H](C(=O)O)[C@@]1(C)CC/C=C(\C)C(=O)OCC(=O)[C@@H]1C[C@H](C(=O)O)[C@@]1(C)CC/C=C(\C)C(=O)O
InChI=1S/C14H20O5/c1-8(12(16)17)5-4-6-14(3)10(9(2)15)7-11(14)13(18)19/h5,10-11H,4,6-7H2,1-3H3,(H,16,17)(H,18,19)/b8-5+/t10-,11+,14-/m0/s1InChI=1S/C14H20O5/c1-8(12(16)17)5-4-6-14(3)10(9(2)15)7-11(14)13(18)19/h5,10-11H,4,6-7H2,1-3H3,(H,16,17)(H,18,19)/b8-5+/t10-,11+,14-/m0/s1
UDZRBDXBUYNBCW-NUZNSSQYSA-NUDZRBDXBUYNBCW-NUZNSSQYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ domain
- Source
- ChEMBL
- Binding sites
- PF00335
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL4546270 →
- UniProt UniProt P60033 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL4546270”) →
Other ligands for this protein
Quick navigation to other ligands bound to Q8NG11.
ChEMBL 19
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).